$NBIX
Neurocrine Biosciences Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Neurocrine Biosciences Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is NBIX up today? It is at $156.60, +0.01% on the day and +0.01% pre-market, and our scanner flagged it 94 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NBIX spikes, and full due diligence on NBIX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NBIX 94 times in the last 30 days. Create a free account to track $NBIX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on NBIX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NBIX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystNEUROCRINE BIOSCIENCES INC: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 19, 2026 · todaySources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lyons Gary A Director | Sold (automatic/other) | -15K 0.01% of company | sold 11% | 122K | $2.4M at $163.11 | Nov 17, 26 |
Lyons Gary A Director | Other | 15K 0.01% of company | added 12% | 137K | $805K at $53.64 | Nov 17, 26 |
Morrow George J Director | Sold (automatic/other) | -7K | sold 41% | 10K | $1.1M at $158.18 | Nov 3, 26 |
Morrow George J Director | Other | 7K | added 69% | 18K | $386K at $53.64 | Nov 3, 26 |
Morrow George J Director | Sold (automatic/other) | -8K | sold 42% | 10K | $1.1M at $144.98 | Nov 2, 26 |
Morrow George J Director | Other | 8K | added 72% | 18K | $402K at $53.64 | Nov 2, 26 |
Gano Kyle Officer | Sold (automatic/other) | -332 | sold 0.2% | 155K | $49K at $146.10 | Nov 1, 26 |
Gano Kyle Officer | Other | 614 | added 0.4% | 155K | n/a | Nov 1, 26 |
Morrow George J Director | Sold (automatic/other) | -300 | sold 2.8% | 10K | $45K at $149.00 | Oct 30, 26 |
Morrow George J Director | Other | 300 | added 2.9% | 11K | $16K at $53.64 | Oct 30, 26 |
Abernethy Matt Officer | Sold (automatic/other) | -2K | sold 5.1% | 43K | $363K at $157.20 | Sep 14, 26 |
Boyer David W. Officer | Sold (automatic/other) | -826 | sold 8.7% | 9K | $130K at $157.45 | Sep 14, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.







The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on NBIX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NBIX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
NBIX last traded at $156.60, up 0.01% on the day and up 0.01% pre-market. The price and chart above update live during market hours (4 AM to 8 PM ET).
The NBIX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NBIX 94 times in the last 30 days.
NBIX (Neurocrine Biosciences Inc) trades on XNAS, with a market cap of about $15.85B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NBIX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NBIX discussion
Sign in to ask a question or join the discussion.